Cynthia Butitta
Director/Board Member at UROGEN PHARMA LTD.
Net worth: 1 M $ as of 2024-04-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Christian Itin | M | 59 |
Autolus Ltd.
 Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | 10 years |
| Cyrus Harmon | M | 54 | 18 years | |
| Martin Pulé | M | 51 |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | 10 years |
| Martin Murphy | M | 55 |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | 10 years |
| John Berriman | M | 76 |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | 10 years |
| Ian Clark | M | 62 | 5 years | |
| Sean Bohen | M | 58 | 4 years | |
| Kapil Dhingra | M | 64 |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | 10 years |
| Shane Kovacs | M | 50 | 4 years | |
| Joseph Jimenez | M | 64 | 5 years | |
| Peter Kushner | M | 86 | 18 years | |
| Dong Kim | M | 47 | 3 years | |
| Douglas Carr | M | - | 6 years | |
| Linda Bain | F | 53 |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | 6 years |
| Joseph Anderson | M | 65 |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | 8 years |
| Gregory Russotti | M | 57 | 4 years | |
| Christine Cassiano | F | - | 8 years | |
| Elizabeth Barrett | F | 62 | 5 years | |
| Carlo Rizzuto | M | 53 | 6 years | |
| Kimberly Blackwell | M | 55 | 3 years | |
| Kenneth J. Dow | M | - | - | |
| Alex Driggs | M | 48 | - | |
| Brent Pfeiffenberger | M | - | 1 years | |
| Yi Larson | F | 44 | 3 years | |
| Graham Walmsley | M | 37 | 4 years | |
| Jason Smith | M | 52 | 4 years | |
| Alexander Swan | M | - | 3 years | |
| David Brochu | M | - | 5 years | |
| Gorjan Hrustanovic | M | 35 | 6 years | |
| Olivia Manser | F | - | 2 years | |
| Sandra Horning | M | 75 | 4 years | |
| J. Garland | M | 55 | 1 years | |
| Fred Cohen | M | 67 | 7 years | |
| Stuart Holden | M | 82 | 9 years | |
| Andy Rappaport | M | 66 | 11 years | |
| Alessandro Riva | M | 63 | 3 years | |
| Daphne Quimi | F | 58 | 2 years | |
| Timothy Walbert | M | 57 | 2 years | |
| Hyam Levitsky | M | 66 | 5 years | |
| Julie Dexter | F | - | - | |
| William Young | M | 79 | 3 years | |
| Brent Rice | M | 58 | 3 years | |
| Naseem Zojwalla | M | 51 | 2 years | |
| Henry C. Montgomery | M | 88 |
Catalyst Semiconductor, Inc.
 Catalyst Semiconductor, Inc. SemiconductorsElectronic Technology Catalyst Semiconductor, Inc. engages in the design, development and sale of semiconductor products. Its products are used in communication, computing, industrial automation, consumer and automotive applications. It offers serial and parallel Flash/electrically erasable programmable read only memories (EEPROM), programmable micro-controller supervisory and voltage reference circuits and mixed signal devices. The company was founded in 1985 and is headquartered in Santa Clara, CA. | 24 years |
| Kristin Lanzi | F | - | - | |
| Cindy Romano | F | - | - | |
| Kamesh Kuchimanchi | M | - | 2 years | |
| Bryon Wornson | M | - | 2 years | |
| Sasha Austin | F | - | 3 years | |
| Leana Wen | M | 41 | 2 years | |
| Jeff Bova | M | - | 7 years | |
| Sorin Georgescu | M | 72 |
Catalyst Semiconductor, Inc.
Catalyst Semiconductor, Inc. SemiconductorsElectronic Technology Catalyst Semiconductor, Inc. engages in the design, development and sale of semiconductor products. Its products are used in communication, computing, industrial automation, consumer and automotive applications. It offers serial and parallel Flash/electrically erasable programmable read only memories (EEPROM), programmable micro-controller supervisory and voltage reference circuits and mixed signal devices. The company was founded in 1985 and is headquartered in Santa Clara, CA. | 23 years |
| George Smarandoiu | M | 77 |
Catalyst Semiconductor, Inc.
Catalyst Semiconductor, Inc. SemiconductorsElectronic Technology Catalyst Semiconductor, Inc. engages in the design, development and sale of semiconductor products. Its products are used in communication, computing, industrial automation, consumer and automotive applications. It offers serial and parallel Flash/electrically erasable programmable read only memories (EEPROM), programmable micro-controller supervisory and voltage reference circuits and mixed signal devices. The company was founded in 1985 and is headquartered in Santa Clara, CA. | 22 years |
| James Robinson | M | 54 | 1 years | |
| Marina Konorty | M | - | 13 years | |
| Vincent I. Perrone | M | - | 2 years | |
| Christopher Vann | M | 59 | 8 years | |
| David Myles | M | 62 | 16 years | |
| James Ottinger | M | - | 7 years | |
| Mark Schoenberg | M | 66 | 8 years | |
| Robert Azelby | M | 56 | - | |
| Robert Iannone | M | 57 | 1 years | |
| Moran Mieron | M | 52 | - | |
| Arie Belldegrun | M | 74 | 12 years | |
| Robert Dolski | M | 54 | 1 years | |
| Veronica Hersberger | M | - | 1 years |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Jay Shepard | M | 65 |
Telik, Inc.
 Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA.
NextWave Pharmaceuticals, Inc.
 NextWave Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NextWave Pharmaceuticals, Inc. operates as a pharmaceutical company which focuses on the development and commercialization of products for the treatment of attention deficit hyperactivity disorder. The company was founded by Mahendra G. Shah on September 25, 2006 and is headquartered in New York, NY. | 7 years |
| Lucinda Crabtree | M | 45 | 3 years | |
| Wendy Wee | F | 71 |
Telik, Inc.
Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA.
Connetics Corp.
 Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | 17 years |
| Shawn Tomasello | F | 65 | 7 years | |
| Gil Hakim | M | 54 | 8 years | |
| Osvaldo Flores | M | - | - | |
| Gail L. Brown | M | 73 |
Altair Capital Associates LLC
Telik, Inc.
Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | 3 years |
| Aya Jakobovits | M | 71 | 3 years | |
| David Tanen | M | 52 | - | |
| Peter Pfreundschuh | M | 55 | 2 years | |
| John Johnson | M | 66 | 3 years | |
| Greg Mann | M | - | - | |
| Paul L. Jenkinson | M | 64 | 1 years | |
| Edward W. Cantrall | M | 92 |
Telik, Inc.
Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | 12 years |
| David Chang | M | 64 | 4 years | |
| Jeffrey Wiezorek | M | 52 | - | |
| Steven R. Goldring | M | 80 |
Telik, Inc.
Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | 12 years |
| Ronald Bentsur | M | 58 | 4 years | |
| Wendy K. Wee | F | 71 |
Telik, Inc.
Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | - |
| John Moriarty | M | 56 | 3 years | |
| Francis McCormick | M | 73 | 7 years | |
| Ran Nussbaum | M | 51 | 10 years | |
| Elizabeth Faust | M | 59 | 2 years | |
| John Higgins | M | 54 |
Connetics Corp.
Connetics Corp. BiotechnologyHealth Technology Connetics Corp. develops and commercializes dermatology products. The firm offers remedies for psoriasis in adults, eczema, seborrheic dermatitis, and acne. The company was founded in 1993 and is headquartered in Palo Alto, CA. | 9 years |
| Jay Backstrom | M | 69 | 3 years | |
| Herwig von Morzé | M | 85 |
Telik, Inc.
Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | 8 years |
| Elyse G. Seltzer | M | 59 | 6 years | |
| Richard B. Newman | M | 85 |
Telik, Inc.
Telik, Inc. Pharmaceuticals: MajorHealth Technology Telik, Inc. is an innovative biopharmaceutical company focused on discovering, developing and commercializing novel small molecule drugs to treat serious diseases. Its TELINTRA product is used for treatment of cytopenias due to myelodysplastic syndrome and chemotherapy. The company's product candidates were discovered using its proprietary drug discovery technology TRAP, which enables the rapid and efficient discovery of small molecule drug candidates. Telik was founded in September 1988 and is headquartered in Palo Alto, CA. | 11 years |
| Stephen Mullennix | M | - | 2 years | |
| Claudine Prowse | M | - | - | |
| Matthias Alder | M | 59 | 4 years | |
| Edward Hodgkin | M | 61 |
Autolus Ltd.
Autolus Ltd. BiotechnologyHealth Technology Autolus Ltd. provides biopharmaceutical services. It focuses on the development and commercialisation of engineered t-cell immunotherapy products with extreme efficacy in the treatment of life-threatening cancers. The company was founded by Martin Pule and is headquartered in White City, the United Kingdom. | 4 years |
| Franz Humer | M | 76 | 2 years | |
| Timothy Moore | M | 62 | 3 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 77 | 77.00% |
| United Kingdom | 23 | 23.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Cynthia Butitta
- Personal Network
